Gene Editing by Cystolic Intracellular Delivery

Exclusively Licensed

Gene editing can be performed by introducing gene-editing components into a cell by mechanical cell disruption. Related apparatus, systems, techniques, and articles are also described.

Researchers

Robert Langer / Alexandra Eyerman / Prashant Mali / Marc Lajoie / Armon Sharei / Klavs F. Jensen

Departments: Office of the Institute Professors, Department of Chemical Engineering
Technology Areas: Biotechnology: Biomedical Devices & Systems, DNA & RNA Editing / Drug Discovery and Research Tools: Cell Interrogation
Impact Areas: Healthy Living

  • gene editing through microfluidic delivery
    United States of America | Granted | 12,130,281
  • gene editing by cystolic intracellular delivery
    Canada | Published application
  • gene editing by cystolic intracellular delivery
    Australia | Granted | 2,016,206,870
  • gene editing by cystolic intracellular delivery
    European Patent Convention | Published application
  • gene editing through microfluidic delivery
    Japan | Granted | 7,278,027
  • gene editing through microfluidic delivery
    United States of America | Granted | 11,125,739
  • gene editing by cystolic intracellular delivery
    China | Published application
  • gene editing through microfluidic delivery
    Japan | Published application

Sign up for technology updates

Sign up now to receive the latest updates on cutting-edge technologies and innovations.

More Technologies